Administration of recombinant TSG-6 decreases LPS-induced inflammation (IL-6 and interferon-γ), and improves arthritis and memory after traumatic brain injury in several murine models [25,29,35,36]. Here, TNFAIP6 is linked to arthritic joint disease.